A panel of experts discusses key datasets in leukemia that were presented recently at the American Society of Clinical Oncology [ASCO] 2023 Annual Meeting and the European Hematology Association [EHA] 2023 Congress.
August 31st 2023
Expert perspectives on key data in chronic myeloid leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.
Shared insight from key opinion leaders on clinical trial data in acute lymphoblastic leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.
Following the ASCO 2023 and EHA 2023 Annual Meetings, experts discuss important updates in acute myeloid leukemia.